Balance Labs Stock Buy Hold or Sell Recommendation
| BLNC Stock | USD 0.18 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Balance Labs is 'Strong Sell'. Macroaxis provides Balance Labs buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BLNC positions.
Check out Balance Labs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Balance and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Balance Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Balance |
Execute Balance Labs Buy or Sell Advice
The Balance recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Balance Labs. Macroaxis does not own or have any residual interests in Balance Labs or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Balance Labs' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Balance Labs Trading Alerts and Improvement Suggestions
| Balance Labs generated a negative expected return over the last 90 days | |
| Balance Labs has some characteristics of a very speculative penny stock | |
| Balance Labs currently holds 468.81 K in liabilities. Balance Labs has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Balance Labs until it has trouble settling it off, either with new capital or with free cash flow. So, Balance Labs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Balance Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Balance to invest in growth at high rates of return. When we think about Balance Labs' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 624.59 K. Net Loss for the year was (796.7 K) with profit before overhead, payroll, taxes, and interest of 479.12 K. | |
| Balance Labs currently holds about 227.77 K in cash with (56) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 87.0% of the company shares are held by company insiders |
Balance Labs Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Balance Labs or Industrials sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Balance Labs' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Balance pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Balance Labs Volatility Alert
At this time Balance Labs exhibits very low volatility. Balance Labs is a potential penny stock. Although Balance Labs may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Balance Labs. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Balance instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Balance Labs Fundamentals Vs Peers
Comparing Balance Labs' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Balance Labs' direct or indirect competition across all of the common fundamentals between Balance Labs and the related equities. This way, we can detect undervalued stocks with similar characteristics as Balance Labs or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Balance Labs' fundamental indicators could also be used in its relative valuation, which is a method of valuing Balance Labs by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Balance Labs to competition |
| Fundamentals | Balance Labs | Peer Average |
| Return On Asset | 0.0771 | -0.14 |
| Operating Margin | 0.50 % | (5.51) % |
| Current Valuation | 7.28 M | 16.62 B |
| Shares Outstanding | 21.67 M | 571.82 M |
| Shares Owned By Insiders | 86.51 % | 10.09 % |
| Price To Earning | 13.82 X | 28.72 X |
| Price To Book | 79.24 X | 9.51 X |
| Price To Sales | 8.12 X | 11.42 X |
| Revenue | 624.59 K | 9.43 B |
| Gross Profit | 479.12 K | 27.38 B |
| EBITDA | (552.39 K) | 3.9 B |
| Net Income | (796.7 K) | 570.98 M |
| Cash And Equivalents | 227.77 K | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 468.81 K | 5.32 B |
| Current Ratio | 0.10 X | 2.16 X |
| Book Value Per Share | (0.18) X | 1.93 K |
| Cash Flow From Operations | (56) | 971.22 M |
| Earnings Per Share | (0.04) X | 3.12 X |
| Number Of Employees | 4 | 18.84 K |
| Beta | -0.31 | -0.15 |
| Market Capitalization | 5.09 M | 19.03 B |
| Total Asset | 1.01 M | 29.47 B |
| Retained Earnings | (1.09 M) | 9.33 B |
| Working Capital | (347 K) | 1.48 B |
| Current Asset | 205 K | 9.34 B |
| Current Liabilities | 552 K | 7.9 B |
| Z Score | 4.6 | 8.72 |
| Net Asset | 1.01 M |
Balance Labs Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Balance . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Balance Labs Buy or Sell Advice
When is the right time to buy or sell Balance Labs? Buying financial instruments such as Balance Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Balance Labs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Junk Bonds Funds Thematic Idea Now
Junk Bonds Funds
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Balance Pink Sheet
Balance Labs financial ratios help investors to determine whether Balance Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balance with respect to the benefits of owning Balance Labs security.